1. Home
  2. DAKT vs JANX Comparison

DAKT vs JANX Comparison

Compare DAKT & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$27.22

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$13.24

Market Cap

790.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
JANX
Founded
1968
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
790.3M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
DAKT
JANX
Price
$27.22
$13.24
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$57.36
AVG Volume (30 Days)
547.3K
1.7M
Earning Date
03-04-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$770,283,000.00
$10,000,000.00
Revenue This Year
$13.76
N/A
Revenue Next Year
$7.35
N/A
P/E Ratio
$188.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.24
$12.12
52 Week High
$27.63
$38.42

Technical Indicators

Market Signals
Indicator
DAKT
JANX
Relative Strength Index (RSI) 83.18 42.38
Support Level $25.69 $12.74
Resistance Level $24.96 $13.79
Average True Range (ATR) 1.19 0.68
MACD 0.32 0.10
Stochastic Oscillator 97.46 42.70

Price Performance

Historical Comparison
DAKT
JANX

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: